Chain Pharmacy DTP Pharmaceutical Care Services and Insurance Direct-Billing Network

📌 Background

Prescription routing, chronic disease management, and DTP pharmacies have become the focal points of competition in pharmaceutical retail. In the first half of 2026, Jiuzhoutong's Good Doctor B2C general agency and sales revenue reached 673 million yuan, a year-on-year increase of 19.10%, with total network GMV reaching 1.109 billion yuan, and interest-based e-commerce channels such as Douyin and Kuaishou growing by 65.60% (based on the company's semi-annual report and official website data); during the same period, the gross profit margin of traditional distribution was only 7.26%, forcing the channel to migrate toward high-margin pharmaceutical care services. After chain pharmacies gain access to medical insurance dual-channels and commercial insurance direct-billing, they transform from simply selling drugs to managing patients by disease category.

👤 Target Customers

Chronic and rare disease patients requiring long-term high-value medication such as oncology and autoimmune diseases, as well as insurance companies and pharmaceutical enterprises with commercial insurance direct-billing needs.

💰 Revenue Streams

1) Revenue primarily comes from DTP drug sales price differentials, pharmaceutical marketing and patient management service fees, and chronic disease management service fees paid by insurance companies per service instance or based on management outcomes; 2) Medical insurance dual-channel reimbursement in certain regions also brings stable prescription flows; 3) Follow-up renewals: follow-up management and renewal service fees charged per treatment course or subscription cycle.

🧮 Cost Structure

Costs include professional pharmacy store and cold chain warehousing investments, human resources costs for pharmacists and patient management teams, prescription routing systems, and interface development and maintenance expenses with hospitals and insurance companies.

🛡️ Moat

The established medical insurance dual-channel qualifications and hospital prescription outflow cooperation networks are difficult to replicate quickly, which, combined with patient medication data and commercial insurance direct-billing settlement systems, creates high switching costs.

🔑 Keys to Success

• Secure more medical insurance dual-channel and outpatient special/chronic disease qualifications
• Co-build patient follow-up and adherence management with pharmaceutical enterprises
• Integrate commercial insurance direct-billing settlement with pharmacy ERP systems

⚠️ Risks

• Stricter compliance reviews for out-of-hospital prescriptions
• Transmission of centralized drug procurement price cuts down to retail gross margins

🏢 Cases

• Laobaixing Pharmacy disclosed its DTP and chronic disease management business layout in official announcements
• Jiuzhoutong's semi-annual report emphasized the synergy between professional pharmacies and commercial insurance payments

📊 SWOT Analysis